phys.org·May 15, 2026
Researchers at the IIMCB in Warsaw, led by Prof. Gracjan Michlewski, discovered that a minor variation at the start of an RNA molecule can significantly affect the activation of innate immune antiviral responses in cells.
This discovery highlights the potential for developing targeted RNA-based therapies to modulate immune responses, offering a promising avenue for innovation in antiviral treatments and immunotherapy. This aligns with your interest in RNA research and could inform future research directions or collaborations focused on fine-tuning immune activation through RNA modifications.